Clinical trials have demonstrated that both biosimilars match the reference product's quality, safety and efficacy standards.

CA Rudramurthy BV is bullish on Biocon and DMart, citing strong technical setups and sectoral promise. Biocon’s breakout from ...

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

Bengaluru: A war of words has erupted between Biocon founder Kiran Mazumdar-Shaw and Karnataka Chief Minister Siddaramaiah on ...

The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...

Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd has announced that the European Commission (EC) has ...

Karnataka CM Siddaramaiah and Biocon chief Kiran Mazumdar-Shaw have been up in arms against each other over the heated debate ...

Biocon founder Kiran Mazumdar Shaw and Karnataka Chief Minister Siddaramaiah debated on X over the safety of Covid-19 ...

Biocon Biologics gets EU approval for Denosumab biosimilars Vevzuo & Evfraxy, expanding access to bone disease treatments across Europe.

Biocon founder Kiran Mazumdar-Shaw refutes Karnataka CM's claim linking Covid-19 vaccines to heart attack deaths in Hassan ...